Arcadia Biosciences Achieves Key Resistant Starch Wheat Technology Milestones, Prepares for Commercial Launch | Business Wire

DAVIS, Calif.–(BUSINESS WIRE)–Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology

company, today announced that it's achieved two key technology

milestones in its High Fiber Resistant Starch (RS) Wheat program. First,

through advanced screening and traditional breeding techniques, the

company has developed non-transgenic (non-GM) wheat varieties that

contain up to 94 percent amylose, the highest levels available.

Increased levels of amylose correspond to high levels of resistant

starch, which has been proven to deliver significant health benefits.

Second, these same wheat varieties deliver levels of total dietary fiber

high enough to meet the threshold required by the US Food and Drug

Administration for a “Good Source” of fiber or “High in Fiber”

designation on consumer packaging.

“These milestones are key achievements in the commercial launch plan for

our non-GM wheat ingredients portfolio, delivering health benefits to

consumers and distinct market differentiators to consumer packaged goods

companies,” said Raj Ketkar, president and CEO of Arcadia Biosciences.

“Arcadia’s new wheat varieties will allow people to enjoy the foods they

love with the health benefits of resistant starch and dietary fiber,

while satisfying consumer demand for clean-label, natural foods.”

Arcadia is working with a select number of consumer packaged goods

companies on new, healthier formulations of existing products using both

enriched and whole wheat RS Wheat flour. The company is preparing for an

increase in acres planted during the upcoming US wheat growing season.

Resistant starch has many benefits compared to other types of starch,

particularly in the management of gastrointestinal health and

obesity-related health conditions, such as cardiovascular disease and

type 2 diabetes. It contains higher amounts of amylose, a carbohydrate

molecule that's less vulnerable to digestion. Because it's digested

more slowly, resistant starch has a lower glycemic index, meaning it

doesn't cause a rapid increase in blood glucose levels. Resistant

starch also acts as a nondigestible prebiotic that promotes the growth

of “good bacteria” (probiotics) that improve gut health.

Some of the additional reported health benefits of resistant starch


–. Increased absorption of calcium and other key minerals

–. Improved weight loss through increased feeling of satiety

–. Increased insulin sensitivity – helpful for cardiovascular disease,

type 2 diabetes, metabolic syndrome, obesity and Alzheimer’s disease

–. Increased production of butyrate – an anti-inflammatory which may help

burn body fat and recently consumed fat.

In addition to the benefits of resistant starch, Arcadia’s RS Wheat

varieties produce refined flour and whole grain flour that's naturally

high in fiber. Many products marketed as “high fiber” contain fiber

additives, such as inulin, cellulose and psyllium husk. Arcadia’s RS

Wheat has intrinsically high levels of fiber and can enable food

companies to reduce the use of added fiber sources in their formulations

to simplify their ingredient labels.

Wheat flour is a major part of people’s diets on a global level. In

2015, the global wheat flour market was valued at $200 billion and is

estimated to reach a value of $270 billion by 2022. On average, one

quarter. 500 calories, of Americans’ daily caloric intake comes from

wheat. Arcadia’s RS Wheat varieties have the opportunity to provide

additional, proven health benefits for consumers who want to continue to

enjoy the wheat-based foods they love.

About Arcadia Biosciences, Inc.

Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA) develops

agricultural products that create added value for farmers, enhance human

health and improve the environmental sustainability of agriculture.

Arcadia’s nutrition traits and products are aimed at creating healthier

ingredients and whole foods with lower production costs. Arcadia’s

agronomic performance traits are aimed at making agricultural production

more economically efficient and environmentally sound. For more

information, visit

Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the

meaning of the Private Securities Litigation Reform Act of 1995,

including statements relating to the company’s wheat traits and the

commercialization of these traits. Forward-looking statements are

subject to risks and uncertainties that could cause actual results to

differ materially. Reported results shouldn't be considered as an

indication of future performance. These risks and uncertainties include,

but aren't limited to: the company’s and its partners’ and affiliates’

ability to identify and isolate desired traits. The company’s and its

partners’ ability to develop commercial products incorporating its

traits and complete the regulatory review process for such products. The

company’s compliance with laws and regulations that impact the company’s

business. Changes to such laws and regulations. The company’s future

capital requirements and ability to satisfy its capital needs. The

other risks set forth in the company’s filings with the Securities and

Exchange Commission from time to time, including the risks set forth in

the company’s Annual Report on Form 10-K for the year ended December 31,

2016. These forward-looking statements speak only as of the date hereof,

and Arcadia Biosciences, Inc. disclaims any obligation to update these

forward-looking statements.

Arcadia Biosciences, Inc.
Jeff Bergau
[email protected]